Changes coming in April from the Arizona Opioid Epidemic Act
Beginning April 26, 2018, new laws go into effect regarding the prescribing and dispensing of opioids in the state of Arizona. Additionally, dispensing pharmacists are required to review the PMP record of a patient receiving a schedule II controlled substance for the preceding 12 months. Read on for more information.
Prescriber Mandate to Use PMP effective October 16, 2017
Aug. 17, 2017, the Prescription Monitoring Program integrated with Health Current (HIE). As a result, the mandate to utilize the PMP went into effect Oct. 16, 2017 for prescribers.
F. Beginning the later of October 1, 2017 or sixty days after the statewide health information exchange has integrated the controlled substances prescription monitoring program data into the exchange, a medical practitioner, before prescribing an opioid analgesic or benzodiazepine controlled substance listed in schedule II, III or IV for a patient, shall obtain a patient utilization report regarding the patient for the preceding twelve months from the controlled substances prescription monitoring program's central database tracking system at the beginning of each new course of treatment and at least quarterly while that prescription remains a part of the treatment. Each medical practitioner regulatory board shall notify the medical practitioners licensed by that board of the applicable date. A medical practitioner may be granted a one-year waiver from the requirement in this subsection due to technological limitations that are not reasonably within the control of the practitioner or other exceptional circumstances demonstrated by the practitioner, pursuant to a process established by rule by the Arizona state board of pharmacy.
About the PMP
The Arizona State Board of Pharmacy Controlled Substances Prescription Monitoring Program (PMP) grants system access accounts to practitioners and pharmacists so that they may look up, view, and print controlled substance dispensing information on their specific patients directly via user name and password. Access is granted to individuals only—not to clinics, hospitals, pharmacies, or any other health care facility.
A.R.S. § 36-2606 requires each medical practitioner who is licensed under Title 32 and who possesses a DEA license to register with the CSPMP. Each DEA license should have an associated registration. There is NO fee to the practitioner for this registration. This registration includes: MD, DO, DDS, DMD, DPM, HMD, PA, NP, ND, OD, and, beginning April 26, 2018, dispensing pharmacists.
Residents may register using the hospital DEA number and appropriate suffix.